Easier Generic and Biosimilar Drug Access: Lower Drug Prices.
New rules aim to simplify the market entry of cheaper drug alternatives, known as generics and biosimilars. This will allow companies to offer their products faster, potentially leading to lower pharmacy prices and greater access to treatment for citizens.
Key points
Allows companies to market cheaper drug alternatives (generics and biosimilars) without fear of patent infringement lawsuits for specific drug uses.
The provisions also apply to ongoing legal proceedings, accelerating the introduction of more affordable drugs.
The goal is to increase competition in the pharmaceutical market, which may reduce treatment costs for patients.
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.